Fujita, N., Kato, S., Kawashima, Y., Shinohara, M., Tabata, R., Tanaka, R., Yoneyama, F., Hatakeyama, S. (2026). Efficacy, safety, and cost-effectiveness of reduced vs. full initial dose androgen receptor signaling inhibitors in non-metastatic castration-resistant prostate cancer: A multicenter retrospective study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.371